Protocol for a patient-derived preclinical platform to model tumor-immune interactions and evaluate therapeutic efficacy

Summary: Here, we present a protocol for a preclinical ex vivo platform combining experimental flexibility with preservation of the tumor microenvironment. We outline steps for isolating human peripheral blood mononuclear cells (PBMCs), preparing patient-derived precision-cut tumor slices (PCTSs), c...

Full description

Saved in:
Bibliographic Details
Main Authors: Wen-Hsin Chang, Andrew I. Chin, Ching-Hsien Chen
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:STAR Protocols
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666166725000292
Tags: Add Tag
No Tags, Be the first to tag this record!